Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH3 domain-binding protein 4 pseudogene (LOC100420211, ENSG00000271111) is a nonfunctional DNA segment resembling the coding gene SH3BP4. Pseudogenes such as this typically do not produce functional proteins but may influence gene regulation at the RNA level, such as by acting as miRNA decoys or interfering with gene expression through antisense transcripts. There is no evidence that this pseudogene is involved in normal physiology or disease as a direct target, nor is it targeted by therapeutic compounds. The functional SH3BP4 gene is involved in clathrin-mediated endocytosis and the regulation of the mTOR pathway, but those activities are not attributed to the pseudogene variant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3 domain-binding protein 4 pseudogene.